Subscribe To

Price Alert Latest News Economic Calendar News

CHB / Capitalize on Biotech Growth in China With This ETF

After a rough 2021 that featured the Evergrande Crisis and heavy regulatory measures on technology to keep monopolistic moves in check, investors are eyeing opportunities in China. One of the sectors of interest is the biotech sector. Read More

Demo Live Account See Partner Details

Content Topics

Capitalize

Biotech

Growth

China

With

This

Stock

CHB

Posted: Jul 21 2022, 12:11

Author Name: ETF Trends

CHB News

By ETF Trends
December 27, 2022

Capture the Growth Potential in China's Biotech Sector With This ETF

With China's economy recovering from a real estate development crisis and rising COVID-19 cases in 2022, it only sets up growth potential for 2023. On

By ETF Trends
July 21, 2022

Capitalize on Biotech Growth in China With This ETF

After a rough 2021 that featured the Evergrande Crisis and heavy regulatory measures on technology to keep monopolistic moves in check, investors are

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.